FundedIQ
Health Care

Equiscript: Funding, Investors & Team (Sep 2026)

Equiscript collaborates with eligible organizations to establish and oversee a 340B home delivery pharmacy that complements their existing 340B pharmacy initiatives. With eight years of experience, they excel at identifying vulnerable patients who qualify for 340B but are not currently served by in-house or contracted pharmacies. They have expertise in implementing customized outreach programs to attract these patients to a designated home delivery pharmacy, where a team of dedicated Patient Care Advocates ensures personalized service. This program offers 340B covered entities a focused strategy to enhance their 340B capture rate, while also driving patient compliance and improving continuity of care.

www.equiscript.com LinkedIn North Charleston, United States 101-250 employees
Health Care Hospital B2B B2C
Total raised
$1.0M
Rounds
1
Latest
Seed
Dec 2023

Equiscript has raised $1.0M across 1 funding round on record, the most recent a Seed of $1.0M announced in Dec 2023.

That round is below the $5.0M median round size for Health Care companies tracked on FundedIQ over the last two years.

Equiscript Company Profile and Key Stats

Total funding raised
$1.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$1.0M in Dec 2023
Employees
101-250
reported band
Headquarters
North Charleston, United States

Latest funding round on record: Dec 2023.

Equiscript Funding Rounds

Date
Round
Amount
Seed
$1.0M

Equiscript Founders and Leadership Team

Name
Role
Contact
Michael Burkhold
CEO

No contact details are on record for this team yet.

Equiscript Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,654
$5.0M
29,981
$7.5M
16,790
$3.1M

Equiscript's latest round of $1.0M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Equiscript in Health Care and North Charleston

Companies Similar to Equiscript

Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…

Undisclosed round $14.5M

Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…

Series B $14.9M

People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…

Undisclosed round $47.0M

Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…

Series E $125M

https://metriport.com

Series A $26.0M

There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…

Series A $17.0M

Serif Health provides healthcare price intelligence and contract management solution.

Private Equity $5.7M

Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…

Undisclosed round $5.0M

Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…

Seed $750k

TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…

Series A $10.0M

Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.

Undisclosed round $1.5M

Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…

Undisclosed round $3.0M

Equiscript Funding FAQs

What does Equiscript do?

Equiscript collaborates with eligible organizations to establish and oversee a 340B home delivery pharmacy that complements their existing 340B pharmacy initiatives. With eight years of experience, they excel at identifying vulnerable patients who qualify for 340B but are not currently served by in-house or contracted pharmacies. They have expertise in implementing customized outreach programs to attract these patients to a designated home delivery pharmacy, where a team of dedicated Patient Care Advocates ensures personalized service. This program offers 340B covered entities a focused strategy to enhance their 340B capture rate, while also driving patient compliance and improving continuity of care.

How much funding has Equiscript raised?

Equiscript has raised $1.0M across 1 round on record. The most recent is a Seed of $1.0M announced in Dec 2023.

When did Equiscript last raise funding?

Equiscript's most recent funding round on record is a Seed of $1.0M, announced in Dec 2023.

Who is the CEO of Equiscript?

Michael Burkhold is listed as CEO at Equiscript.

Where is Equiscript headquartered?

Equiscript is based in North Charleston, South Carolina, United States.

How many employees does Equiscript have?

Equiscript is in the 101-250 employee band.

How does Equiscript's funding compare to other Health Care startups?

Equiscript's latest round of $1.0M is below the $5.0M median round size for Health Care companies on FundedIQ across 3,654 tracked companies over the last two years.

About FundedIQ's Equiscript Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Equiscript is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.